Immunoassays Market Report Predicts Huge Growth with Focus on ELISA, Specimens and Technology Insights

The global immunoassays market in 2021 was $24.30 billion, and it will be worth $45.82 billion by 2030 at a 24.30% CAGR from 2021 to 2030. Immunoassays (IAs) are bioanalytical techniques that rely on the reaction of an antigen and an antibody to quantify analytes. Immunoassays are used in a variety of bioanalytical applications, including clinical diagnostics, security, biopharmaceutical analysis, environmental monitoring, and food testing. Due to their inherent high throughput, specificity, and high sensitivity for identifying diverse analytes in biological samples, immunoassay methods are significant and effective in pharmaceutical research.

To get a first-hand overview of the report, Request a Sample at

https://www.strategicmarketresearch.com/request-sample/immunoassay-market

Immunoassays Market Insights: 

• The reagents and kits segment contributed for a revenue share of more than 60% in 2021 on the basis of product.
• With a market share of 60%, the EIA/ELISA segment ruled the overall market in 2021 on the basis of technology.
• In 2021, the infectious disease testing segment held a significant position with a revenue share of 35% in terms of application.
• By end-user, the hospital segment ruled the market in 2021 with a revenue share of 30%.
• Geographically, in 2021 North America led the market with a share of about 35%.

Immunoassays Market Dynamics

Globally, the incidence and frequency of cancer cases are significantly rising; consequently, the use of immunoassay for early cancer diagnosis and monitoring is gradually expanding. As per WHO, nearly 2.09 million people worldwide will have lung cancer in 2021, and 2.27 million more people will have lung cancer in 2022. Over the years, immunoassays have been one of the rapidly expanding clinical diagnostics technologies. The growth of the immunoassay market has been encouraged by the technological developments in immunoassays fuelled by the demand for early illness detection.

To read the summary of the report, visit the website at

https://www.strategicmarketresearch.com/market-report/immunoassay-market

Immunoassays Market: A thorough Segmentation Analysis

The worldwide Immunoassays Market segmentation has been done on the basis of type, technique, product, specimen type, application, end-user, and region.

By Type:

• Fluoroimmunoassay (FIA)
• Colloidal Gold Immnunochromatographic Assay
• Radioimmunoassay (RIA)
• Enzyme Immunoassays (EIA)
• Chemiluminescenceimmunoassay (CLIA)
• Electrochemiluminescence Immunoassay (ECL)

By Technique

• Rapid Tests
• CD/DVD-based immunoassay
• Western Blotting
• Immuno PCR
• Enzyme-Linked Immunospot
• Enzyme-Linked Immunosorbent Assays
• Other Techniques

By product:

• Analyzers
• Reagents and Kits

By Specimen Type:

• Urine
• Blood
• Saliva
• Others

By Application:

• Thyroid
• Allergies
• Endocrinology
• Hematology
• Infectious Diseases
• Oncology or Cancer Diagnostics
• Respiratory diseases
• Cardiology
• Others

By End-User

• Clinical Laboratories
• Hospitals
• Pharma & Biotech Companies
• Others

By Region

• The Middle East and Africa
• North America
• Asia Pacific
• Europe
• LAMEA

Make a Direct Purchase of the latest Immunoassays Market Report published in the month of Jul-2022. Click the below link to initiate the purchase: 

https://www.strategicmarketresearch.com/buy-now/immunoassay-market

The reagents and kits segment contributed for a revenue share of more than 60% in 2021 on the basis of product. Over the forecast period, the segment is anticipated to keep up its position. Due to the rising incidence of viral & autoimmune disorders, there is a huge demand for immunoassay reagents & kits for diagnostic purposes. Additionally, it is also anticipated that the approval & introduction of innovative immunoassay kits will help the segment's expansion.

Geographically, in 2021 North America led the market with a share of about 35%. This can be linked to the increasing demand for diagnostics caused by the rise in cancer incidence and the ease of access to technologically enhanced diagnostic tools. Furthermore, the region's high prevalence of infectious diseases such as tuberculosis, HIV, and influenza is increasing the need for treatment and diagnosis.

Key players in Immunoassays Market:

• BioCheck
• Abbott
• BioMerieux SA
• Meso Scale Diagnostics
• PerkinElmer Inc
• Agilent Technologies
• Beckman Coulter
• Bio-Techne
• Luminex Corporation
• Thermo Fisher Scientific
• Siemens
• Randox Laboratories LTD
• QIAGEN
• Merck KGaA
• Ortho Clinical Diagnostics
• Shenzhen Mindray Bio-Medical Electronics
• Quidel Corporation
• F. Hoffmann-La Roche Ltd
• Bio-Rad Laboratories
• DiaSorin S.p.A

The Immunoassay Market will reach $45.82 billion by 2030, growing at a 7.3% CAGR from 2021 to 2030. The rising prevalence of acute and chronic infectious diseases, combined with an aging population, technological advancements in immunoassays, rising awareness for early disease diagnosis, increased use of immunoassays in oncology and drug & alcohol testing, and the occurrence of COVID-19 are the key factors driving the immunoassays market's growth. 

Related Reports:

Microsurgical Instruments Market

https://www.strategicmarketresearch.com/market-report/microsurgical-instruments-market

Wireless Charging Market

https://www.strategicmarketresearch.com/market-report/wireless-charging-market

Hemostats And Tissue Sealants Market

https://www.strategicmarketresearch.com/market-report/hemostats-and-tissue-sealants-market

Gate-All-Around FET Technology Market

https://www.strategicmarketresearch.com/market-report/-gaafet-technology-market

Automotive Wiring Harness Market

https://www.strategicmarketresearch.com/market-report/automotive-wiring-harness-market